Sleep Deprivation Reduces Tear Secretion and Impairs the Tear Film
1 other identifier
interventional
20
1 country
1
Brief Summary
Tear film consists of three layers including outer lipid layer, aqueous layer and inner mucin layer.1,2 Lipid layer protects the aqueous layer of tear film from evaporation and mucin layer adhere the tear film to ocular surface. Aqueous layer, which is produced in lacrimal glands, is the most important in the health of ocular surface. Reduction of aqueous tear secretion results in the disruption of homeostasis at ocular surface and leads to dry eye syndrome.2 Dry eye syndrome is a common ocular surface disease associated with symptoms of eye discomfort, grittness and visual disturbance.1,2 Dry eye syndrome disrupts normal homeostasis at the ocular surface resulting in epithelial damage, epithelial cell apoptosis, loss of goblet cells, and squamous metaplasia.1-3 The changes and inflammation of ocular surface subsequently lead to tear instability, which causes an increased tear osmolarity and aggravates the inflammatory cascades. This leads to a vicious cycle.2 The regulation of tear film secretion is under neural and hormonal control.4 Dry eye syndrome has been associated with diverse and multiple causes, including depressive disorder, drugs, hormonal status, and systemic diseases.2 Sleep deprivation (SD) is known to cause profound impair¬ments in executive function and vigilant attention.5,6 It is also reportedly associated with autonomic and endocrine functioning7-9 and has been shown to increase blood pressure and stress hormone levels and decrease parasympathetic tone.10,11 Tear secretion is regulated by neurological factors and hormones,12 and so SD may have an effect on the tear film and ocular surface. However, only a few studies have evaluated the effect of sleep on the tear film and ocular surface. In this study, we investigated the effect of SD on the tear film and ocular surface.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Dec 2012
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2013
CompletedFirst Submitted
Initial submission to the registry
January 2, 2014
CompletedFirst Posted
Study publicly available on registry
January 3, 2014
CompletedJanuary 3, 2014
January 1, 2014
2 months
January 2, 2014
January 2, 2014
Conditions
Outcome Measures
Primary Outcomes (1)
Tear osmolarity measurement
A microcapillary glass tube (Marienfeld, Lauda-Königshofen, Germany) was placed on the lower outer conjunctival sac. To avoid reflex tearing, the subjects were asked to direct their gaze supranasally. A total of 30 µL of tears was taken from the marginal tear strip. After centrifugation at 3000 rpm for 3 min, supernatants were obtained and the samples were stored at -80 degree. Tear osmolarity was measured using a Multi-OSMETTE 2430 (Precision Systems Inc., Natick, MA, USA).
1 day
Secondary Outcomes (4)
Visual analog pain score
1 day
Tear break up time
1 day
Intraocular pressure
1 day
Schirmer's test
1 day
Study Arms (2)
sleep deprivation
EXPERIMENTALTen subjects in the SD group were examined after a SD experiment in which they did not sleep for 24 h.
control
NO INTERVENTIONThe 10 subjects in the control group were not sleep deprived (had 8 h of sleep).
Interventions
Eligibility Criteria
You may qualify if:
- Twenty healthy young male volunteers aged 20-30 years
You may not qualify if:
- Subjects with dry eye symptoms within the previous 6 months were excluded from the study.
- Subjects have any systemic diseases such as systemic lupus, rheumatoid arthritis, Sjögren's syndrome or a history of ocular disease.
- Subjects have disorder of lid margin, nasolacrimal duct, and cornea.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hallym University, Kangnam Sacred Heart Hospital
Seoul, 150-950, South Korea
Related Publications (1)
Lee YB, Koh JW, Hyon JY, Wee WR, Kim JJ, Shin YJ. Sleep deprivation reduces tear secretion and impairs the tear film. Invest Ophthalmol Vis Sci. 2014 May 15;55(6):3525-31. doi: 10.1167/iovs.14-13881.
PMID: 24833736DERIVED
Study Officials
- PRINCIPAL INVESTIGATOR
Young Joo Shin
Hallym University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD
Study Record Dates
First Submitted
January 2, 2014
First Posted
January 3, 2014
Study Start
December 1, 2012
Primary Completion
February 1, 2013
Study Completion
February 1, 2013
Last Updated
January 3, 2014
Record last verified: 2014-01